• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫喷妥钠用于难治性惊厥性癫痫持续状态时伴发的抗癫痫药浓度降低:一例报告

Thiamylal serum concentration for refractory convulsive status epilepticus while associated decreased concentrations of concomitant antiepileptics: a case report.

作者信息

Oda Kazutaka, Katanoda Tomomi, Arakaki Hitomi, Katsume Taiki, Matsuyama Kaho, Jono Hirofumi, Saito Hideyuki

机构信息

Department of Pharmacy, Kumamoto University Hospital, 1-1-1Chuo-Ku, Kumamoto City, HonjoKumamoto, Japan.

Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 1-1-1Chuo-Ku, Kumamoto City, HonjoKumamoto, Japan.

出版信息

J Pharm Health Care Sci. 2024 Jul 12;10(1):39. doi: 10.1186/s40780-024-00362-w.

DOI:10.1186/s40780-024-00362-w
PMID:38997787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11245824/
Abstract

BACKGROUND

Treating refractory status epilepticus (RSE) remains a challenge. Thiamylal can be used as a second- or third-line treatment; however, its potential to induce cytochrome P450 (CYP) activity may reduce the concentration of antiepileptic drugs (AEDs) administered prior to thiamylal. This report details a case of RSE patient treated with thiamylal, with monitored concentrations of thiamylal and other AEDs.

CASE PRESENTATION

A 72-year-old healthy man developed RSE. Despite the administration of various AEDs, his seizures were not resolved. Thiamylal was then administered at an initial bolus dose of 2.1 mg/kg, followed by a continuous infusion of 4.2-5.2 mg/kg/h. The initial thiamylal concentration was observed at 7.8 μg/mL, increasing to 35.2 μg/mL before decreasing after dose reduction and cessation. Concurrently, the concentration of concomitant carbamazepine decreased from 5.59 μg/mL to 2.1 μg/mL and recovered as thiamylal concentration decreased. Lesser impacts were noted for other AEDs.

CONCLUSIONS

This case report underscored the efficacy of thiamylal in treating RSE. However, it also highlighted the need for clinicians to closely monitor the concentrations of concurrent AEDs, especially carbamazepine, during thiamylal therapy.

摘要

背景

治疗难治性癫痫持续状态(RSE)仍然是一项挑战。硫喷妥钠可作为二线或三线治疗药物;然而,其诱导细胞色素P450(CYP)活性的可能性可能会降低在使用硫喷妥钠之前所给予的抗癫痫药物(AEDs)的浓度。本报告详细介绍了一例接受硫喷妥钠治疗的RSE患者,监测了硫喷妥钠和其他AEDs的浓度。

病例介绍

一名72岁健康男性发生了RSE。尽管使用了各种AEDs,但他的癫痫发作仍未得到缓解。随后给予硫喷妥钠,初始推注剂量为2.1mg/kg,随后以4.2 - 5.2mg/kg/h的速度持续输注。观察到硫喷妥钠的初始浓度为7.8μg/mL,在剂量减少和停药前增加到35.2μg/mL,随后下降。同时,同时使用的卡马西平浓度从5.59μg/mL降至2.1μg/mL,并随着硫喷妥钠浓度的降低而恢复。其他AEDs受到的影响较小。

结论

本病例报告强调了硫喷妥钠治疗RSE的疗效。然而,它也强调了临床医生在硫喷妥钠治疗期间密切监测同时使用的AEDs浓度的必要性,尤其是卡马西平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68d6/11245824/e38f71e13ab0/40780_2024_362_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68d6/11245824/e38f71e13ab0/40780_2024_362_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68d6/11245824/e38f71e13ab0/40780_2024_362_Fig1_HTML.jpg

相似文献

1
Thiamylal serum concentration for refractory convulsive status epilepticus while associated decreased concentrations of concomitant antiepileptics: a case report.硫喷妥钠用于难治性惊厥性癫痫持续状态时伴发的抗癫痫药浓度降低:一例报告
J Pharm Health Care Sci. 2024 Jul 12;10(1):39. doi: 10.1186/s40780-024-00362-w.
2
Evaluation for Blood Concentration and Efficacy/Safety of Continuous Administration of Thiamylal in Children.评价硫喷妥钠在儿童中持续给药时的血药浓度和疗效/安全性。
Ther Drug Monit. 2024 Jun 1;46(3):397-403. doi: 10.1097/FTD.0000000000001153. Epub 2023 Nov 27.
3
Thiamylal anaesthetic therapy for febrile refractory status epilepticus in children.硫喷妥钠麻醉治疗儿童难治性热性惊厥持续状态。
Seizure. 2020 Aug;80:12-17. doi: 10.1016/j.seizure.2020.03.012. Epub 2020 May 14.
4
Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.难治性惊厥性癫痫持续状态的治疗:美国癫痫协会治疗委员会的全面综述
Epilepsy Curr. 2020 Sep;20(5):245-264. doi: 10.1177/1535759720928269. Epub 2020 Aug 21.
5
Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.拉科酰胺用于治疗儿童难治性癫痫持续状态:一项意大利多中心研究经验
Eur J Paediatr Neurol. 2014 Sep;18(5):604-8. doi: 10.1016/j.ejpn.2014.04.013. Epub 2014 Apr 24.
6
Ketamine use in the treatment of refractory status epilepticus.氯胺酮在难治性癫痫持续状态中的应用。
Epilepsy Res. 2013 Jul;105(1-2):183-8. doi: 10.1016/j.eplepsyres.2013.01.007. Epub 2013 Jan 29.
7
Treatment of Convulsive Status Epilepticus.癫痫持续状态的治疗。
Curr Treat Options Neurol. 2016 Mar;18(3):11. doi: 10.1007/s11940-016-0394-5.
8
Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study.托吡酯辅助治疗耐药性癫痫持续状态患者:一项观察性队列研究。
CNS Drugs. 2012 Sep 1;26(9):761-72. doi: 10.2165/11633090-000000000-00000.
9
Early polytherapy for benzodiazepine-refractory status epilepticus.苯二氮䓬类药物难治性癫痫持续状态的早期联合治疗。
Epilepsy Behav. 2019 Dec;101(Pt B):106367. doi: 10.1016/j.yebeh.2019.06.011. Epub 2019 Oct 18.
10
The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center.托吡酯治疗成人难治性癫痫持续状态的疗效:一家三级医疗中心的经验。
Epilepsy Res. 2012 Feb;98(2-3):232-7. doi: 10.1016/j.eplepsyres.2011.09.017. Epub 2011 Oct 15.

本文引用的文献

1
A novel step-down infusion method of barbiturate therapy: Its safety and effectiveness for intracranial pressure control.新型降压式巴比妥酸盐治疗方法:其控制颅内压的安全性和有效性。
Pharmacol Res Perspect. 2021 Apr;9(2):e00719. doi: 10.1002/prp2.719.
2
Predictors of outcome in refractory generalized convulsive status epilepticus.难治性全面性惊厥性癫痫持续状态的预后预测因素。
Epilepsia Open. 2020 Apr 22;5(2):248-254. doi: 10.1002/epi4.12394. eCollection 2020 Jun.
3
Thiamylal anaesthetic therapy for febrile refractory status epilepticus in children.
硫喷妥钠麻醉治疗儿童难治性热性惊厥持续状态。
Seizure. 2020 Aug;80:12-17. doi: 10.1016/j.seizure.2020.03.012. Epub 2020 May 14.
4
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.随机对照试验三种抗癫痫药物治疗癫痫持续状态。
N Engl J Med. 2019 Nov 28;381(22):2103-2113. doi: 10.1056/NEJMoa1905795.
5
Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study.在东芬兰的癫痫持续状态不同阶段的发病率:一项基于人群的研究。
Epilepsy Behav. 2019 Dec;101(Pt B):106413. doi: 10.1016/j.yebeh.2019.07.014. Epub 2019 Jul 29.
6
The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist.新型抗癫痫药物吡仑帕奈的临床药理学特征:一种新型非竞争性 AMPA 受体拮抗剂。
Epilepsia. 2015 Jan;56(1):12-27. doi: 10.1111/epi.12865. Epub 2014 Dec 13.
7
[Acute encephalitis with refractory partial status epilepticus treated with early immunotherapies including plasma exchange: a case report].[采用包括血浆置换在内的早期免疫疗法治疗的伴有难治性部分性癫痫持续状态的急性脑炎:一例报告]
Rinsho Shinkeigaku. 2014;54(9):715-20. doi: 10.5692/clinicalneurol.54.715.
8
Treatment of convulsive status epilepticus in infants and young children in Japan.日本婴幼儿惊厥性癫痫持续状态的治疗
Acta Neurol Scand Suppl. 2007;186:62-70.
9
Seizure after local anesthesia for nasopharyngeal angiofibroma.鼻咽血管纤维瘤局部麻醉后癫痫发作。
Kaohsiung J Med Sci. 2007 Feb;23(2):97-100. doi: 10.1016/S1607-551X(09)70383-3.
10
Therapeutic drug monitoring of old and newer anti-epileptic drugs.新旧抗癫痫药物的治疗药物监测
Clin Chem Lab Med. 2004;42(11):1228-55. doi: 10.1515/CCLM.2004.245.